finger frame of sunset

Who we are

Newron is a biopharmaceutical company focused on developing novel therapies for patients with diseases of the central and peripheral nervous system. Our scientific work centers around the development of novel therapeutic classes to address unmet needs in difficult-to-treat indications such as Parkinson’s disease, schizophrenia, and other underserved areas in which there has been limited innovation for decades.

Founded in 1999, Newron is headquartered in Bresso, near Milan, Italy, and has a subsidiary in Morristown, NJ, USA. With a heritage of more than 25 years of proprietary scientific research and clinical development, our experienced team of around 30 scientists, researchers, and clinicians brings drug candidates from discovery to commercialization.

Our success is rooted in strong clinical research and longstanding partnerships with specialized pharmaceutical companies, helping to bring novel treatments to patients worldwide. (find more here Science > Partnering).

We are committed to delivering innovative treatments to improve the quality of life for patients with CNS disorders. Our team has built a balanced and robust pipeline comprised of drug candidates at different clinical stages and has a proven track record of drug development and commercialization.

Investors

Newron shares are listed on SIX Swiss Exchange under the ticker symbol NWRN, on the primary market of the Düsseldorf Stock Exchange and on XETRA, trading symbol NP5.

We are committed to providing reliable and transparent information about our business in an open and timely manner. Click Read more to find investment and shareholder information, including our latest share price, key financial data and presentations and webcasts.

Upcoming events

Add to calendar

June 3 -5, 2025 - Marriott Marquis, New York City, USA

Jefferies Global Healthcare Conference

More events

May 12-14, 2025 - Frankfurt | Main, Germany

German Spring Conference 2025

June 3 -5, 2025 - Marriott Marquis, New York City, USA

Jefferies Global Healthcare Conference

June 16-17, 2025

H.C. Wainwright 6th Annual Neuro Perspectives Conference

Growing Plant

What we do

Newron is committed to developing novel therapies for patients with diseases of the central and peripheral nervous system. We are looking to build our portfolio of products through in-house efforts as well as licensing and acquiring novel CNS compounds at various stages of development.

Man sitting at his desk in front of a laptop

Our people

Leadership Team with Significant Expertise